Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cipla Australia is the regional subsidiary of Cipla Limited, a leading global pharmaceutical company dedicated to providing affordable and high-quality generic medicines. The company maintains a significant presence in the Australian healthcare market, with a primary focus on respiratory care, oncology, and hospital-based therapies. Cipla Australia is particularly recognized for its extensive portfolio of inhalation products used in the management of asthma and chronic obstructive pulmonary disease. By leveraging its parent company's robust research and manufacturing infrastructure, Cipla Australia ensures the delivery of essential medications across various therapeutic areas, including anti-infectives and cardiovascular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cipla Australia.